SMTL ID : 5fxs.1

IGFR-1R complex with a pyrimidine inhibitor.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

monomer

Ligands

3 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 4 residues within 4Å: Chain A: R.18, I.21, P.96, L.98 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.98 Salt bridges: A:R.18 ACT.2: 2 residues within 4Å: Chain A: T.105, R.106 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:T.105 Water bridges: A:R.106 Salt bridges: A:R.106 ACT.3: 4 residues within 4Å: Chain A: R.106, S.111, Y.112 Ligands: OZN.4 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.111

1 x OZN: 2-[4-[4-[[(6Z)-5-chloranyl-6-pyrazolo[1,5-a]pyridin-3-ylidene-1H-pyrimidin-2-yl]amino]-3,5-dimethyl-pyrazol-1-yl]piperidin-1-yl]-N,N-dimethyl-ethanamide(Non-covalent)

OZN.4: 13 residues within 4Å: Chain A: L.27, V.35, A.53, M.101, E.102, M.104, T.105, G.107, D.108, M.164, D.175, M.178 Ligands: ACT.3 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.27, A:L.27 Hydrogen bonds: A:M.104, A:M.104 Water bridges: A:D.108 Halogen bonds: A:D.175

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Degorce, S.L. et al., Discovery of a Potent, Selective, Orally Bioavailable, and Efficacious Novel 2-(Pyrazol-4-ylamino)-pyrimidine Inhibitor of the Insulin-like Growth Factor-1 Receptor (IGF-1R). J. Med. Chem. (2016)

Release Date

2016-10-19

Peptides

INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR